AKR1B10 expression is elevated and correlated with poor prognosis in several types of cancers like hepatocellular carcinoma (23), breast carcinoma (24–26), lung cancer (27–29) and oral cancer (30–32), but is quite opposite in colorectal cancer (33–37). Here, AKR1B10 is linked to lung cancer.